| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Vivo Opportunity, LLC is a 10% Owner at SOLENO THERAPEUTICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 5 buys and 17 sells.
Estimated insider holdings value: $250.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | SLNO Soleno Therapeutics Inc | 10% Owner | Sell | 1,833,557 | $67.87 | $124,449,124.20 | -10.8% | +16.7% | -58.3% | |
| Aug 29, 2024 | SLNO Soleno Therapeutics Inc | 10% Owner | Sell | 1,025,000 | $48.01 | $49,210,750.00 | -5.0% | +19.9% | +45.3% | |
| Apr 30, 2024 | SLNO Soleno Therapeutics Inc | 10% Owner | Sell | 1,101,242 | $46.95 | $51,701,551.46 | -6.8% | +4.8% | +67.6% | |
| Apr 3, 2024 | TERN Terns Pharmaceuticals, Inc. | 10% Owner | Sell | 420,663 | $6.65 | $2,796,859.03 | -2.2% | +12.0% | -61.2% | |
| Dec 23, 2022 | TERN Terns Pharmaceuticals, Inc. | 10% Owner | Buy | 758,620 | $7.25 | $5,499,995.00 | +21.2% | +10.3% | -20.5% | |
| Sep 7, 2022 | TERN Terns Pharmaceuticals, Inc. | 10% Owner | Buy | 600,000 | $3.60 | $2,160,000.00 | +20.1% | +54.2% | +37.6% | |
| Aug 16, 2022 | TERN Terns Pharmaceuticals, Inc. | 10% Owner | Buy | 2,624,239 | $2.66 | $6,980,244.40 | +79.1% | -7.2% | +14.3% |